Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FNTA | P49354 | 2/20 | 0.54 |
| ▸ | FNTB | P49356 | 2/20 | 0.54 |
| ▸ | THRB | P10828 | 1/20 | 0.54 |
| ▸ | PGGT1B | P53609 | 1/20 | 0.54 |
| ▸ | FFAR3 | O14843 | 3/20 | 0.42 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.42 |
| ▸ | GRIK1 | P39086 | 2/20 | 0.37 |
| ▸ | GRIA4 | P48058 | 1/20 | 0.37 |
| ▸ | GRIK3 | Q13003 | 1/20 | 0.37 |
| ▸ | GRIK5 | Q16478 | 1/20 | 0.37 |
| ▸ | LCK | P06239 | 1/20 | 0.33 |
| ▸ | FYN | P06241 | 1/20 | 0.33 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.30 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.30 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.30 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL554290 | 1.00 | FNTA (0.54) | FNTAFNTBTHRBPGGT1BFFAR3 | |
| SCHEMBL164727 | 1.00 | FNTA (0.54) | FNTAFNTBTHRBPGGT1BFFAR3 | |
| SCHEMBL304615 | 0.97 | FNTA (0.52) | FNTAFNTBTHRBPGGT1BFFAR3 | |
| SCHEMBL304617 | 0.97 | FNTA (0.52) | FNTAFNTBTHRBPGGT1BFFAR3 | |
| SCHEMBL2547697 | 0.86 | FNTA (0.46) | FNTAFNTBTHRBPGGT1BFFAR3 | |
| SCHEMBL30198647 | 0.86 | FNTA (0.41) | FNTAFNTBTHRBPGGT1BFFAR3 | |
| SCHEMBL1300238 | 0.83 | FNTA (0.45) | FNTAFNTBTHRBPGGT1BFFAR3 | |
| SCHEMBL1556595 | 0.81 | FNTA (0.39) | FNTAFNTBTHRBPGGT1BFFAR3 | |
| SCHEMBL8852386 | 0.81 | FNTA (0.43) | FNTAFNTBTHRBPGGT1BFFAR3 | |
| SCHEMBL101165 | 0.81 | FFAR3 (0.53) | FNTAFNTBTHRBPGGT1BFFAR3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 157 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220105064-A1 | CONTROLLED RELEASE PHARMACEUTICAL COMPOSITIONS COMPRISING A FUMARIC ACID ESTER | BIOGEN SWISS MFG GMBH (CH) | 2022-04-07 | — | — | US | claimed |
| US-20220079884-A1 | PHARMACEUTICAL FORMULATION COMPRISING ONE OR MORE FUMARIC ACID ESTERS IN AN EROSION MATRIX | BIOGEN SWISS MFG GMBH (CH) | 2022-03-17 | — | — | US | claimed |
| US-11229619-B2 | Controlled release pharmaceutical compositions comprising a fumaric acid ester | BIOGEN SWISS MANUFACTURING GMBH (CH) | 2022-01-25 | — | — | US | claimed |
| US-20190201368-A1 | CONTROLLED RELEASE PHARMACEUTICAL COMPOSITIONS COMPRISING A FUMARIC ACID ESTER | BIOGEN SWISS MANUFACTURING GMBH (CH) | 2019-07-04 | — | — | US | claimed |
| US-20190117613-A1 | CONTROLLED RELEASE PHARMACEUTICAL COMPOSITIONS COMPRISING A FUMARIC ACID ESTER | BIOGEN SWISS MANUFACTURING GMBH (CH) | 2019-04-25 | — | — | US | claimed |
| CN-109044985-A | Pharmaceutical preparation comprising one of corrosion skeleton or a variety of fumarates | 前进制药知识产权有限公司 | 2018-12-21 | — | — | CN | claimed |
| US-20180325855-A1 | CONTROLLED RELEASE PHARMACEUTICAL COMPOSITIONS COMPRISING A FUMARIC ACID ESTER | FWP IP APS (DK) | 2018-11-15 | — | — | US | claimed |
| US-20180263947-A1 | CONTROLLED RELEASE PHARMACEUTICAL COMPOSITIONS COMPRISING A FUMARIC ACID ESTER | BIOGEN SWISS MANUFACTURING GMBH (CH) | 2018-09-20 | — | — | US | claimed |
| US-20180221284-A1 | PHARMACEUTICAL FORMULATION COMPRISING ONE OR MORE FUMARIC ACID ESTERS IN AN EROSION MATRIX | BIOGEN SWISS MANUFACTURING GMBH (CH) | 2018-08-09 | — | — | US | claimed |
| US-20180098957-A1 | CONTROLLED RELEASE PHARMACEUTICAL COMPOSITIONS COMPRISING A FUMARIC ACID ESTER | BIOGEN SWISS MANUFACTURING GMBH (CH) | 2018-04-12 | — | — | US | claimed |
| US-20090304790-A1 | CONTROLLED RELEASE PHARMACEUTICAL COMPOSITIONS COMPRISING A FUMARIC ACID ESTER | ADITECH PHARMA AB (SE) | 2009-12-10 | — | — | US | claimed |
| US-20080299196-A1 | Controlled Release Pharmaceutical Compositions Comprising a Fumaric Acid Ester | ADITECH PHARMA AB (SE) | 2008-12-04 | — | — | US | claimed |
| EP-1951206-A1 | CONTROLLED RELEASE PHARMACEUTICAL COMPOSITIONS COMPRISING A FUMARIC ACID ESTER | Aditech Pharma AB (SE) | 2008-08-06 | — | — | EP | claimed |
| EP-1409566-B1 | PHOTOCROSSLINKING OF DIETHYL FUMARATE/POLY(PROPYLENE FUMARATE) BIOMATERIALS | UNIV WM MARSH RICE (US) | 2008-04-23 | — | — | EP | claimed |
| EP-1799196-A2 | CONTROLLED RELEASE PHARMACEUTICAL COMPOSITIONS COMPRISING A FUMARIC ACID ESTER | Aditech Pharma AB (SE) | 2007-06-27 | — | — | EP | claimed |
| WO-2007042034-A1 | CONTROLLED RELEASE PHARMACEUTICAL COMPOSITIONS COMPRISING A FUMARIC ACID ESTER | ADITECH PHARMA AB (SE) | 2007-04-19 | — | — | WO | claimed |
| WO-2006037342-A2 | CONTROLLED RELEASE PHARMACEUTICAL COMPOSITIONS COMPRISING A FUMARIC ACID ESTER | ADITECH PHARMA AB (SE) | 2006-04-13 | — | — | WO | claimed |
| EP-1131065-B1 | DIALKYLFUMARATES FOR THE TREATMENT OF AUTOIMMUNE DISEASES | FUMAPHARM AG (CH) | 2003-06-11 | — | — | EP | claimed |
| EP-1131065-A2 | UTILISATION OF DIALKYLFUMARATES | Fumapharm AG (CH) | 2001-09-12 | — | — | EP | claimed |
| WO-2000030622-A2 | UTILISATION OF DIALKYLFUMARATES FOR TREATING HOST-VERSUS-GRAFT REACTIONS AND AUTO-IMMUNE DISEASES | FUMAPHARM AG (CH) | 2000-06-02 | — | — | WO | claimed |